INTEGRATED PROTEINS LTD.

Integrated Proteins Limited has announced Friday, September 4, 2026, as the record date for its equity share sub-division. The company's members approved the split of equity shares with a face value of ₹10 each into 10 equity shares of ₹1 each at an Extra Ordinary General Meeting held on August 20, 2026. This corporate action aims to increase the liquidity and affordability of the company's shares.

Integrated Proteins Ltd announced that its Board of Directors has considered and approved the unaudited financial results for the quarter ended June 30, 2026. The results were presented along with a limited review report from the auditors. The board meeting took place on August 14, 2026, from 13:00 to 15:50 IST. The company reported a revenue from operations of ₹1,054.73 Lakhs for the quarter, with a profit after tax of ₹36.26 Lakhs. This filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Integrated Proteins Ltd announced the outcome of its Board of Directors meeting held on August 14, 2026. The board considered and approved the unaudited financial results for the quarter ended June 30, 2026, along with the limited review report from the auditors. The meeting commenced at 13:00 IST and concluded at 15:50 IST. The company submitted these results in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Integrated Proteins Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The meeting will also review the limited review report for the said period. In compliance with SEBI regulations regarding insider trading, the trading window for company personnel will remain closed until 48 hours after the results are declared.

Integrated Proteins Ltd has announced an Extra Ordinary General Meeting (EGM) scheduled for August 20, 2026, to be held via Video Conferencing. The key agenda items include the sub-division/split of equity shares from a face value of ₹10 to ₹1, alteration of the Memorandum of Association's capital clause, and the regularization of Mr. Nitish Pratapray Mehta as a Non-Executive Non-Independent Director and Mr. Hiren Dhirajlal Shah as Chairman and Managing Director. The notice is in compliance with Listing Regulations, and the EGM details are available on the company's website.

Integrated Proteins Ltd announced that its Board of Directors, in a meeting held on July 24, 2026, approved the redesignation of Mr. Hiren Shah from Additional Executive Director to Chairman and Managing Director. This appointment is subject to shareholder approval and is for a term of five years, commencing July 24, 2026, and ending July 23, 2031. Mr. Shah possesses a BCA and LL.B. degree and has extensive experience in finance, accounting, business administration, and corporate management. The company also announced the date for its Extra-Ordinary General Meeting (EGM) on August 20, 2026, to discuss this and other matters, with e-voting available from August 17 to August 19, 2026.

Integrated Proteins Ltd announced that its Board of Directors, in a meeting held on July 24, 2026, approved the re-designation of Mr. Hiren Dhirajlal Shah from Additional Executive Director to Chairman and Managing Director. This appointment is subject to shareholder approval and will be for a term of five years, commencing July 24, 2026. The board also approved convening an Extra-Ordinary General Meeting (EOGM) on August 20, 2026, to be held via Video Conferencing/Other Audio Visual Means, to discuss and approve the notice and explanatory statement. Mrs. Ankita Tejas Shah has been appointed as the scrutinizer for the e-voting process, which will run from August 17 to August 19, 2026.

Integrated Proteins Ltd has filed an application with BSE seeking a 'no-objection' for the reclassification of 10 individuals from the 'Promoter and Promoter Group' category to the 'Public' category. These individuals, including Vinod Prabhulal Mehta and Amrish Vinod Mehta, collectively held a small percentage of shares. The application is made in accordance with Regulation 31A of the SEBI LODR Regulations, following request letters received on July 7, 2026. The company is seeking approval for this change in shareholding classification.

Integrated Proteins Ltd announced a revised board meeting outcome held on July 9, 2026. The board approved a sub-division (split) of equity shares, where one existing equity share of face value ₹10 will be split into ten equity shares of face value ₹1 each. This is subject to shareholder and regulatory approvals. Additionally, the board approved reclassification requests from the Promoter & Promoter Group to the 'Public' category, pending 'No Objection Certificates' from stock exchanges. The meeting also noted the resignations of Mr. Priyansh Tejas Parekh (Independent Director), Ms. Neepa Praful Kothari (Director), and Mr. Vinod Prabhulal Mehta (Executive Director), citing professional and personal reasons.

Integrated Proteins Limited's Board of Directors has approved requests from several promoter and promoter group shareholders to reclassify their status to 'Public' category. This decision aligns with SEBI LODR Regulations, specifically Regulation 31A, provided the outgoing promoters meet all stipulated conditions. These conditions include not controlling company affairs, lacking special rights, not having board representation (except for Vinod Prabhulal Mehta), not acting as key managerial persons, and not being willful defaulters or fugitive economic offenders. The reclassification is subject to shareholder and stock exchange approvals. The board unanimously passed the resolution, with only Vinod Prabhulal Mehta having some interest due to his continued role.